返回 Agendas
Session 10: Adaptive Design and Bayesian Working Group Feedback
Session Chair(s)
Lei Nie, PHD
Director, Division of Biometrics IV, Office of Biostatistics, OTS, CDER
FDA, United States
Zoran Antonijevic, MSC
Vice President, Statistical Consulting
Abond CRO Inc., United States
Over the past few years, the DIA has established several multi-disciplinary Scientific Working Groups (SWGs) which bring together representatives from Industry, Government and Academia to address a specific unresolved research problem related to drug development. Two of the most active SWGs are the Adaptive Designs SWG and the Bayesian SWG. This session will highlight recent developments from these ongoing activities. In particular, the speakers will outline how these developments can accelerate the drug development process
Speaker(s)
Speaker
Zoran Antonijevic, MSC
Abond CRO Inc., United States
Vice President, Statistical Consulting
Speaker
David Ohlssen, PHD
Novartis Pharmaceuticals Corporation, United States
Senior Expert Methodologist
Panelist (joining the Speakers):
Estelle Russek-Cohen, PHD
FDA, United States
Senior Advisor, Office of Biostat